Baidu
map

JAMA Surg:腹腔镜胃束带二次手术影响因素

2017-05-19 zhangfan MedSci原创

胃束带设备因素导致的再手术十分常见、花费巨大且与手术位置相关

自2001年FDA批准腹腔镜胃束带手术后,每年约进行96000起手术。短期研究表明胃束带手术后再手术率为4-60%,但尚无针对胃束带手术效果的长期人口基数研究。近日研究人员就腹腔镜胃束带手术后设备原因导致的再手术开展研究。

研究包括2006-2013年间进行的25042起胃束带手术,包括设备移除,设备更换或改变减肥计划。使用多变量逻辑回归模型分析再手术率的风险。主要终点是全国或地区设备相关的再手术率及造成的医疗花费。

研究期间共进行25042起再手术,其中82.61%的患者为白人,72.45%的患者为女性,平均年龄57.56岁。高血压糖尿病与再手术风险无关,但多数再手术患者是在营利性医院进行手术(34.6% vs 22.0%; P<0.001)。平均随访4.5年后,有4636名患者再次进行手术(18.5%),再手术发生率与手术位点相关,调整后的再手术风险差距为2.9倍(胃下1/4 vs胃上1/4 :13.3% vs 39.1%)。研究期间,胃束带手术花费4.7亿美元,其中胃束带再手术花费2.24亿(47.6%)美元。2006年至2013年间,胃束带再手术花费占患者医疗保险支出由16.4%上升到77.3%

研究发现,胃束带设备因素导致的再手术十分常见、花费巨大且与手术位置相关。

原始出处:


本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2085125, encodeId=0200208512504, content=<a href='/topic/show?id=c1362394449' target=_blank style='color:#2F92EE;'>#二次手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23944, encryptionId=c1362394449, topicName=二次手术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de89102, createdName=liuyong2980, createdTime=Tue Sep 05 07:33:00 CST 2017, time=2017-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276369, encodeId=364e12e636931, content=<a href='/topic/show?id=768685612db' target=_blank style='color:#2F92EE;'>#腹腔镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85612, encryptionId=768685612db, topicName=腹腔镜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Sun May 21 06:33:00 CST 2017, time=2017-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1465537, encodeId=4d87146553ea7, content=<a href='/topic/show?id=144f5032688' target=_blank style='color:#2F92EE;'>#影响因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50326, encryptionId=144f5032688, topicName=影响因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80a06745918, createdName=chenzhuanggui, createdTime=Sun May 21 06:33:00 CST 2017, time=2017-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=200051, encodeId=082b20005108, content=这个也是我需要了解的地方, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Fri May 19 16:22:20 CST 2017, time=2017-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=200044, encodeId=aea720004455, content=不错的文章,值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Fri May 19 16:14:40 CST 2017, time=2017-05-19, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2085125, encodeId=0200208512504, content=<a href='/topic/show?id=c1362394449' target=_blank style='color:#2F92EE;'>#二次手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23944, encryptionId=c1362394449, topicName=二次手术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de89102, createdName=liuyong2980, createdTime=Tue Sep 05 07:33:00 CST 2017, time=2017-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276369, encodeId=364e12e636931, content=<a href='/topic/show?id=768685612db' target=_blank style='color:#2F92EE;'>#腹腔镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85612, encryptionId=768685612db, topicName=腹腔镜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Sun May 21 06:33:00 CST 2017, time=2017-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1465537, encodeId=4d87146553ea7, content=<a href='/topic/show?id=144f5032688' target=_blank style='color:#2F92EE;'>#影响因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50326, encryptionId=144f5032688, topicName=影响因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80a06745918, createdName=chenzhuanggui, createdTime=Sun May 21 06:33:00 CST 2017, time=2017-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=200051, encodeId=082b20005108, content=这个也是我需要了解的地方, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Fri May 19 16:22:20 CST 2017, time=2017-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=200044, encodeId=aea720004455, content=不错的文章,值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Fri May 19 16:14:40 CST 2017, time=2017-05-19, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2085125, encodeId=0200208512504, content=<a href='/topic/show?id=c1362394449' target=_blank style='color:#2F92EE;'>#二次手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23944, encryptionId=c1362394449, topicName=二次手术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de89102, createdName=liuyong2980, createdTime=Tue Sep 05 07:33:00 CST 2017, time=2017-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276369, encodeId=364e12e636931, content=<a href='/topic/show?id=768685612db' target=_blank style='color:#2F92EE;'>#腹腔镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85612, encryptionId=768685612db, topicName=腹腔镜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Sun May 21 06:33:00 CST 2017, time=2017-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1465537, encodeId=4d87146553ea7, content=<a href='/topic/show?id=144f5032688' target=_blank style='color:#2F92EE;'>#影响因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50326, encryptionId=144f5032688, topicName=影响因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80a06745918, createdName=chenzhuanggui, createdTime=Sun May 21 06:33:00 CST 2017, time=2017-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=200051, encodeId=082b20005108, content=这个也是我需要了解的地方, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Fri May 19 16:22:20 CST 2017, time=2017-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=200044, encodeId=aea720004455, content=不错的文章,值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Fri May 19 16:14:40 CST 2017, time=2017-05-19, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2085125, encodeId=0200208512504, content=<a href='/topic/show?id=c1362394449' target=_blank style='color:#2F92EE;'>#二次手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23944, encryptionId=c1362394449, topicName=二次手术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de89102, createdName=liuyong2980, createdTime=Tue Sep 05 07:33:00 CST 2017, time=2017-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276369, encodeId=364e12e636931, content=<a href='/topic/show?id=768685612db' target=_blank style='color:#2F92EE;'>#腹腔镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85612, encryptionId=768685612db, topicName=腹腔镜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Sun May 21 06:33:00 CST 2017, time=2017-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1465537, encodeId=4d87146553ea7, content=<a href='/topic/show?id=144f5032688' target=_blank style='color:#2F92EE;'>#影响因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50326, encryptionId=144f5032688, topicName=影响因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80a06745918, createdName=chenzhuanggui, createdTime=Sun May 21 06:33:00 CST 2017, time=2017-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=200051, encodeId=082b20005108, content=这个也是我需要了解的地方, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Fri May 19 16:22:20 CST 2017, time=2017-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=200044, encodeId=aea720004455, content=不错的文章,值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Fri May 19 16:14:40 CST 2017, time=2017-05-19, status=1, ipAttribution=)]
    2017-05-19 131****2916

    这个也是我需要了解的地方

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2085125, encodeId=0200208512504, content=<a href='/topic/show?id=c1362394449' target=_blank style='color:#2F92EE;'>#二次手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23944, encryptionId=c1362394449, topicName=二次手术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de89102, createdName=liuyong2980, createdTime=Tue Sep 05 07:33:00 CST 2017, time=2017-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276369, encodeId=364e12e636931, content=<a href='/topic/show?id=768685612db' target=_blank style='color:#2F92EE;'>#腹腔镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85612, encryptionId=768685612db, topicName=腹腔镜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Sun May 21 06:33:00 CST 2017, time=2017-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1465537, encodeId=4d87146553ea7, content=<a href='/topic/show?id=144f5032688' target=_blank style='color:#2F92EE;'>#影响因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50326, encryptionId=144f5032688, topicName=影响因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80a06745918, createdName=chenzhuanggui, createdTime=Sun May 21 06:33:00 CST 2017, time=2017-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=200051, encodeId=082b20005108, content=这个也是我需要了解的地方, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Fri May 19 16:22:20 CST 2017, time=2017-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=200044, encodeId=aea720004455, content=不错的文章,值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Fri May 19 16:14:40 CST 2017, time=2017-05-19, status=1, ipAttribution=)]
    2017-05-19 1e1b8538m79(暂无匿称)

    不错的文章,值得学习

    0

相关资讯

Lancet:长期减肥计划成本-受益越高

超重或肥胖成年人,超过12周的成人保健减重方案才能达到预期效果。52周计划比12周的计划产生更大的减肥和其他临床效益,虽然成本更高但符合长期成本效益

JCEM:催产素有助于减肥和骨质疏松的治疗?!

催产素(OXT)是一种对骨骼产生合成代谢的厌食性的下丘脑激素,并且可能反映能量的可用性。在神经性厌食症患者中(AN,能量缺乏状态)的基础血清OXT水平低于健康对照组(HC),且基础血清OXT值与脊柱骨密度(BMD)呈负相关。然而,OXT水平在超重/肥胖者(OB,能量过剩状态)的报告中与消瘦者相应结果是矛盾的。此外,OXT和超重者BMD以及髋关节几何关系是未知的。

多篇文章共同解析禁食疗法的好与坏!

近年来,一种名为间歇性禁食或者5:2饮食的一种疗法/策略在人群中广为流行,很多名人和媒体都认为这种饮食方式可以降低血压、增加机体寿命以及保护机体抵御各种疾病,比如痴呆症等;当然有些研究人员还通过研究发现,一段时间的禁食能够帮助抵抗自身免疫病的发生,包括红斑狼疮与多发性硬化等等。 但到底禁食疗法真的如科学家们研究的那样能够给人类机体带来诸多益处吗?有研究者就通过研究发现,这样的饮食方式

Diabetes Care:心脏代谢疾病分期预测通过减肥预防2型糖尿病的有效性

近期,一项发表在杂志Diabetes Care上的研究评估了药物辅助减肥以预防糖尿病的能力,并评估了基线心脏代谢疾病分期(CMDS)评分的功能。研究者们将3,040名超重和肥胖受试者的数据汇总在三项随机对照试验中-CONQUER,EQUIP和SEQUEL,以评估苯丁胺/托吡酯延长释放(ER)对减肥的疗效和安全性。在这些双盲III期试验中,超重/肥胖成年患者接受生活方式的干预治疗,随机分配到安慰剂对

Radiology:减肥可减缓关节退行性改变

肥胖是骨关节炎已知的危险因素,是造成美国居民残疾的主要原因之一。一项最新研究提供的证据表明,减肥可以减缓膝关节骨性关节炎的进展,减少膝关节软骨的退化。

NEJM:有氧耐力运动+体重控制可提高老年人身体机能

减肥加有氧-耐力运动是最有效的改善肥胖老年人机体功能状态的方法

Baidu
map
Baidu
map
Baidu
map